Ditas Labs Profile
Key Indicators
- Authorised Capital ₹ 7.00 Cr
as on 15-11-2024
- Paid Up Capital ₹ 6.87 Cr
as on 15-11-2024
- Company Age 3 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2023)
- Profit 10.01%
(FY 2023)
- Ebitda
- Net Worth -0.39%
(FY 2023)
- Total Assets 0.04%
(FY 2023)
About Ditas Labs
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 7.00 Cr and a paid-up capital of Rs 6.87 Cr, as per Ministry of Corporate Affairs (MCA) records.
Venkata Suvarna, Nitika Duddilla, Srinivas Duddilla, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24230TG2021PTC150900
- Company No.
150900
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Apr 2021
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Ditas Labs?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Venkata Suvarna  | Director | 03-Jun-2021 | Current |
| Nitika Duddilla | Director | 03-Jun-2021 | Current |
| Srinivas Duddilla | Director | 23-Apr-2021 | Current |
| Chaturya Yarlagadda | Director | 23-Apr-2021 | Current |
| Yarlagadda Chowdhary | Director | 23-Apr-2021 | Current |
Financial Performance of Ditas Labs.
Ditas Labs Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 10.01% increase in profit. The company's net worth dipped by a decrease of 0.39%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Ditas Labs?
In 2022, Ditas Labs had a promoter holding of 68.08% and a public holding of 31.92%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Spiro Infra Projects Private LimitedActive 13 years 1 monthNitika Duddilla and Srinivas Duddilla are mutual person
- Ditas Infra Private LimitedActive 3 years 8 months
Nitika Duddilla and Srinivas Duddilla are mutual person
- Dataformix Enterprise Solutions Private LimitedActive 13 years 8 months
Nitika Duddilla and Srinivas Duddilla are mutual person
- Sri Phoenixe Drugs & Chemicals Private LimitedActive 4 years 10 months
Yarlagadda Chowdhary is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ditas Labs?
Ditas Labs has a workforce of 0 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ditas Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ditas Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
